Claudin-4: A new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin

This publication has 37 references indexed in Scilit:

• TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system
  International Journal of Cancer, 2001
• TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo
  Gene Therapy, 2000
• TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
  Cell, 2000
• TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation
  Oncogene, 2000
• Intraarterial Instillation of Microencapsulated Cells in the Pancreatic Arteries in Pig
  Annals of the New York Academy of Sciences, 1999
• Injection of Encapsulated Cells Producing an Ifosfamide‐Activating Cytochrome P450 for Targeted Chemotherapy to Pancreatic Tumors
  Annals of the New York Academy of Sciences, 1999
• Regional Celiac Artery Infusion as Adjuvant Treatment after Pancreatic Cancer Resection
  Digestion, 1997
• Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes
  Toxicology, 1994
• Protective effects of osmotic stabilizers on morphological and permeability alterations induced in vero cells by Clostridium perfringens enterotoxin
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1981
• The effects of Clostridium perfringens enterotoxin on morphology, viability, and macromolecular synthesis in vero cells
  Journal of Cellular Physiology, 1979